webinar register page

Webinar banner
FDA Discusses Challenges and Opportunities for 3D Printing in Life Sciences - A "Straight from the Source" Webinar


Nov 20, 2019 10:30 AM

Webinar logo
* Required information


Matthew Di Prima, Ph.D.
Co-Chair of the Additive Manufacturing Working Group @U.S. FDA Office of Science and Engineering Laboratories (OSEL)
Dr. Di Prima is a research materials scientist at the Center for Devices and Radiological Health at the US FDA. His areas of research are additive manufacturing, corrosion and durability testing, and explant analysis. Along with his research duties, he is the co-Chair of the Additive Manufacturing Working Group which is spearheading efforts across the Agency to address how this technology affects regulated medical products.
Eric M. Luyer
Industry Research Analyst @Axendia, Inc.
His current focus includes the practical use of new technologies in Life Science markets and his coverage areas include Enterprise Asset Management (EAM), Service Management, Mobility, Internet of (Medical) Things, Cloud, as well as Asset Performance Management (APM) with links to IOT/Business Analytics – Big Data, 3D Printing (Additive Manufacturing) and the application of Augmented / Virtual Reality (AR/VR) and Robotics in the Life Sciences industry. He has authored numerous articles and white papers on technology trends and their impact on Life Sciences and Healthcare markets. Before joining AXENDIA, Eric was responsible for worldwide Manufacturing/Life Sciences Industry Marketing at IBM Corp./Maximo EAM for more than twelve years. Eric has held senior positions in Market Management, Sales, Alliance & Partner Management in major software vendors in Financials, ERP, EAM.